No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
CN Stock MarketDetailed Quotes
002750 Kunming Longjin Pharmaceutical
- 2.57
- -0.13-4.81%
Market Closed Dec 17 15:00 CST
1.03BMarket Cap-19.18P/E (TTM)
2.73High2.57Low107.94KlotVolume2.72Open2.70Pre Close28.13MTurnover2.71%Turnover RatioLossP/E (Static)400.50MShares11.5052wk High2.05P/B1.02BFloat Cap1.4352wk Low2.84Limit Up398.74MShs Float26.32Historical High2.57Limit Down5.93%Amplitude1.43Historical Low--Dividend TTM2.61Avg Price69.47KlotAsk--Div YieldTTM100Lot Size37.96KlotBid
Intraday
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
*Special Treat Longjin (002750.SZ): Received the pharmaceutical registration certificate for sildenafil citrate orally disintegrating tablets.
ST Longjin (002750.SZ) released an announcement that the company's controlling subsidiary, Yunnan Longjin Kangyou Biomedical Co., Ltd...
*ST Longjin: 2024 Third Quarter Report
*ST Longjin: 2024 Semi-Annual Report Summary
*ST Longjin: 2024 Semi-Annual Report
ST Longjin (002750.SZ) released its performance for the first half of the year, with a net loss of 4.224 million yuan.
*ST Longjin (002750.SZ) released its 2024 semi-annual report, during the reporting period, the company achieved operating income...
Special treat Longjin (002750.SZ): As of August 9, the number of shareholders in the company was 38,065.
On August 14th, Gelunhui reported that as of the latest date of August 9, 2024, the number of shareholders in Special Treat Longjin (002750.SZ) was 38,065.
